The Efficacy and Safety of Sintilimab Combined With Nab-Paclitaxel as a Second-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer

医学 内科学 癌症 养生 临床终点 肿瘤科 化疗 不利影响 紫杉醇 进行性疾病 性能状态 胃肠病学 实体瘤疗效评价标准 无进展生存期 随机对照试验
作者
Jianzheng Wang,Yunduan He,Baiwen Zhang,Huifang Lv,Caiyun Nie,Beibei Chen,Weifeng Xu,Jing Zhao,Xiaojiao Cheng,Qingli Li,Shuiping Tu,Xiaobing Chen
出处
期刊:Frontiers in Oncology [Frontiers Media]
卷期号:12: 924149-924149 被引量:14
标识
DOI:10.3389/fonc.2022.924149
摘要

Background: Unresectable advanced or recurrent gastric cancer patients have a poor prognosis. PD-1 monotherapy regimen and PD-1 combined chemotherapy regimen have become the standard third- and first-line treatment for advanced gastric cancer, respectively. However, the status of immune checkpoint inhibitors in the second-line treatment for advanced gastric cancer has not been established. The combination of chemotherapy and anti-PD-1 antibody has been demonstrated to have a synergistic effect. In this study, we aimed to evaluate the efficacy and safety of sintilimab combined with nab-paclitaxel in the second-line treatment for advanced gastric cancer (GC)/gastroesophageal junction (GEJ) cancer patients. Patients and Methods: We retrospectively analyzed patients with advanced GC/GEJ cancer that progressed after first-line systemic therapies with sintilimab combined with nab-paclitaxel from April 1, 2019 to December 31, 2021. The primary endpoint was progression-free survival (PFS). The secondary endpoints included objective response rate (ORR), disease control rate (DCR), and safety. Results: Thirty-nine patients were enrolled and eligible for response assessment. Complete response (CR) was not observed, 15 patients achieved partial response (PR), 16 patients had stable disease (SD) and 9 patients had progressive disease (PD). The ORR and DCR were 15 (38.5%) and 31 (79.5%), respectively. Median PFS was 5.4 months (95%CI: 3.072-7.728). PFSs between different subgroups were analyzed. The results showed that gender, age, Human epidermal growth factor receptors 2 (HER2) status, PD-L1 expression, primary tumor site and chemotherapy cycles had no significant effect on PFS. Most of the adverse events (AEs) were of grade 1-2 and manageable. The common treatment-related adverse events of grade 3 or 4 included anemia (12.8%), neutropenia (12.8%), leukopenia (10.3%), hand-foot syndrome (7.7%), thrombocytopenia (7.7%). The potential immune-related adverse events (irAEs) were grade 1 pneumonia (1 pts [2.6%]) and grade 4 hepatitis (1 pts [2.6%]). There were no treatment-related deaths. Conclusion: These results indicate that sintilimab combined with nab-paclitaxel exhibits good anti-tumor activity and an acceptable safety profile as a second-line treatment for advanced or metastatic gastric cancer. These results warrant further investigation and evaluation to identify patients who can benefit more from the combined treatment strategy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小太阳完成签到,获得积分10
刚刚
肆yyy完成签到 ,获得积分10
刚刚
斯文败类的应助被科研通管家采纳,获得10
1秒前
成就的初瑶完成签到,获得积分10
1秒前
赘婿的应助被科研通管家采纳,获得10
1秒前
CodeCraft的应助被科研通管家采纳,获得10
1秒前
SamYang完成签到,获得积分10
1秒前
Akim的应助被科研通管家采纳,获得10
1秒前
1秒前
1秒前
Chi_2026发布了新的文献求助10
1秒前
NexusExplorer的应助被科研通管家采纳,获得10
1秒前
无极微光的应助被科研通管家采纳,获得20
1秒前
妞妞完成签到,获得积分10
1秒前
WLJlele发布了新的文献求助10
1秒前
2秒前
diaoyulao发布了新的文献求助10
2秒前
小福星完成签到,获得积分10
2秒前
脑洞疼的应助被科研通管家采纳,获得10
2秒前
Donnie完成签到,获得积分10
2秒前
Akim的应助被科研通管家采纳,获得10
2秒前
DW的应助被科研通管家采纳,获得10
2秒前
王不留行完成签到 ,获得积分10
2秒前
开朗月饼完成签到,获得积分10
2秒前
hmjhj发布了新的文献求助10
2秒前
呜呜呜啦完成签到,获得积分10
2秒前
vampv的应助被科研通管家采纳,获得10
2秒前
wanci的应助被科研通管家采纳,获得10
2秒前
syvshc的应助被科研通管家采纳,获得10
2秒前
hihj完成签到,获得积分10
2秒前
共享精神的应助被科研通管家采纳,获得10
2秒前
3秒前
慕青的应助被科研通管家采纳,获得10
3秒前
yinxinyi关注了科研通微信公众号
3秒前
小蘑菇的应助被科研通管家采纳,获得10
3秒前
共享精神的应助被阿飞采纳,获得10
3秒前
汉堡包的应助被科研通管家采纳,获得10
3秒前
852的应助被科研通管家采纳,获得10
3秒前
3秒前
黑球发布了新的文献求助10
3秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180586
求助须知:如何正确求助?哪些是违规求助? 9570581
关于积分的说明 21813457
捐赠科研通 7776777
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557547
邀请新用户注册赠送积分活动 2479253